Kyrgyzstan Medical Device Recalls and Field Corrective Actions: The Leading Role of the Authorized Representative

1. Key takeaways

In Kyrgyzstan, recalls and field corrective actions legally belong to the post-market surveillance system: Annex 2 to Cabinet Resolution No. 513 establishes the surveillance procedure, and Article 14 of Law No. 216 places the reporting obligation on the manufacturer or its authorized representative. At the execution level, a foreign manufacturer cannot carry out a recall on its own — the authorized representative must lead, because the representative is the resident entity in Kyrgyzstan, bears responsibility for compliance, and holds the electronic system accounts and the channel contact routes.

2. Legal basis

1. Cabinet Resolution No. 513, August 27, 2024, Annex 2: the Procedure for Monitoring the Safety, Quality and Effectiveness of Medical Devices.
2. Article 14 of Law No. 216: the obligation to report changes in device data and information rests with the manufacturer or its authorized representative.
3. Article 15 of Law No. 216: grounds for suspension and revocation of registration certificates.
4. Article 2 of Annex 1 to Cabinet Resolution No. 513: the authorized representative of the manufacturer is a resident entity of Kyrgyzstan and bears responsibility for the placing on the market of devices and for compliance with mandatory requirements.
5. Cabinet Resolution No. 450, June 29, 2026: procedures for inspections in the distribution stage.

Source note: the specific procedures, reporting deadlines and forms of competent authority involvement for recalls and field corrective actions were not available this round in official wording suitable for verbatim citation. This article therefore does not state a specific number of days; the original text of Annex 2 to Cabinet Resolution No. 513 prevails.

3. Expert insights

Insight one: in a recall, the authorized representative acts as the executor, not merely as a contact point.

Article 2 of Annex 1 to Cabinet Resolution No. 513 defines the authorized representative as the entity that bears responsibility for the placing on the market of devices and for compliance with mandatory requirements imposed on them. A recall is the most direct intervention in the distribution stage. This means that notifying the channel, withdrawing products from shelves, recovering goods and reporting to the competent authority can only be executed by the authorized representative. The manufacturer’s role is decision-making and resource support.

Insight two: recall and surveillance are two ends of the same system.

Surveillance (articles 41–43 of this series) detects problems; recalls deal with them. Both draw on the same data sources, the same channel files and the same interface to the competent authority. We recommend building the recall plan as a component of the surveillance system rather than as a standalone document — so that when an event occurs, the data, the channel records and the contacts are already in place.

Insight three: the channel file determines whether a recall can actually land.

The distributor channel file recommended in article 39 of this series (entity information, license numbers, territories covered, list of products sold, complaint contacts and adverse event reporting routes) converts directly into an execution tool in a recall scenario: knowing where the goods are, who holds them, and whom to call. We recommend adding a batch flow field to the channel file, recording which distributor received each batch, so that the recall scope can be pinpointed.

Insight four: recalls and changes usually go hand in hand.

A recall is typically followed by product improvements, label updates or revisions to the instructions for use. These are all changes to the registration dossier, which require review and approval (article 35), and after 2028 they can only be handled under the Union rules. We recommend building a change assessment step into the recall plan so that, once the field action is complete, the process does not stall at the change pathway.

Insight five: recall records are a focal point during inspections.

Cabinet Resolution No. 450 extends inspections into the distribution stage. Execution records of recalls and field corrective actions are the core evidence that a company has fulfilled its post-market obligations. We recommend retaining in full: recall decision documents, notification records, recovery lists, disposal records, effectiveness assessments and reports to the competent authority.

4. Practical recommendations

First, merge the recall plan into the surveillance system and share data and channels. We recommend including a recall chapter in the surveillance system documentation, sharing the channel files, contact lists and the interface to the competent authority.

Second, add a batch flow field to the channel file. We recommend recording which distributor each batch was shipped to, along with quantities and dates, to enable precise recall targeting.

Third, allocate recall responsibilities and costs in agreements. We recommend stipulating that the manufacturer is responsible for decisions and resource support while the authorized representative is responsible for execution and reporting, and that recall costs are allocated according to responsibility.

Fourth, build a change assessment step into the plan. We recommend setting a checkpoint in the recall process: does the corrective plan involve product improvements or label updates? If so, initiate the change application in parallel, factoring in the December 31, 2028 pathway constraint.

Fifth, retain complete records of the entire recall process. We recommend archiving six categories: decision documents, notification records, recovery lists, disposal records, effectiveness assessments, and reports to the competent authority.

Sixth, conduct periodic drills. We recommend exercising the recall process at least once a year to test the accuracy of the channel files and the speed of response.

5. Verification checklist

• □ The recall plan has been merged into the surveillance system, sharing channel files and contact lists;
• □ A batch flow field has been added to the channel file (distributor, quantity, date);
• □ Agreements specify recall responsibilities (manufacturer for decisions and resources, authorized representative for execution and reporting) and cost allocation;
• □ The recall process includes a change assessment checkpoint, factoring in the December 31, 2028 pathway constraint;
• □ Records of the entire recall process are archived in six categories: decisions, notifications, recovery lists, disposal, effectiveness assessments, reports;
• □ The original text of Annex 2 to Cabinet Resolution No. 513 has been obtained to verify recall procedures and reporting requirements;
• □ An annual recall drill mechanism is in place.

Regulatory information verified as of October 29, 2026.

Our services cover pre-market pathway selection and feasibility assessment, registration dossier preparation and submission, authorized representative arrangements, local testing and clinical trial organization, manufacturing site inspection coordination, quality management system conformity support, post-market surveillance and vigilance system setup, import and distribution compliance, and fee calculation and project budget management.

The GRZAN regulatory team consists of professionals with many years of hands-on experience in Eurasian Economic Union registrations and has built stable local cooperation networks in Bishkek, Almaty, Tashkent and Moscow. Working in Chinese, Russian and English, we deliver actionable solutions for foreign manufacturers on the key issues commonly encountered in CIS markets, including authorized representative arrangements, notarization and legalization chains for powers of attorney, localization of technical documentation, and inspection readiness.

We hold to one principle: every regulatory conclusion we publish must be traceable to verifiable official sources; figures and timelines that cannot be verified are always marked as practical estimates and are never presented as legal requirements drawn from experience.

GRZAN provides registration and compliance support in this country for manufacturers, importers and authorized representatives. For project inquiries on market access in Kyrgyzstan or the Eurasian Economic Union, please contact us at info@grzanglobal.com.

GRZAN | Global Regulatory Registration and Compliance Services for Medical Devices